X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/19/2901311/0/en/OnKure-Announces-the-Appointment-of-Rogan-Nunn-J-D-as-General-Counsel-and-Secretary.html
https://www.globenewswire.com/news-release/2024/05/13/2880338/0/en/Reneo-Pharmaceuticals-and-OnKure-Announce-Proposed-Merger.html
https://www.fiercebiotech.com/biotech/onkure-hitches-reneos-ride-nasdaq-65m-pipe-boot
https://www.globenewswire.com//news-release/2023/09/20/2746594/0/en/OnKure-Therapeutics-Appoints-Ann-Howell-Pharm-D-as-Vice-President-of-Regulatory-Affairs.html
https://www.globenewswire.com/news-release/2023/05/23/2674144/0/en/OnKure-Therapeutics-Announces-54-Million-Series-C-Financing.html
https://endpts.com/onkure-therapeutics-nabs-60m-as-hdac-inhibitor-awaits-solid-tumor-readouts/
https://www.globenewswire.com/news-release/2022/06/21/2465957/0/en/OnKure-Therapeutics-Appoints-Kevin-S-Litwiler-Ph-D-as-Senior-Vice-President-of-DMPK-and-Clinical-Pharmacology.html
https://www.globenewswire.com/news-release/2022/06/02/2455007/0/en/OnKure-Therapeutics-Announces-First-Patient-Dosed-in-the-Phase-1b-2-Nautilus-Trial-of-OKI-179-in-Combination-with-Binimetinib-in-Patients-with-Advanced-NRAS-Mutated-Melanoma.html
https://www.globenewswire.com/news-release/2022/04/25/2427976/0/en/OnKure-Therapeutics-Expands-Boulder-Footprint-with-the-Opening-of-a-New-Research-Laboratory.html
https://www.globenewswire.com/news-release/2022/04/08/2419432/0/en/OnKure-Therapeutics-Announces-Promising-Preclinical-Data-on-OKI-179-in-RAS-Mutated-Tumor-Models-Presented-in-a-Late-Breaking-Session-at-AACR.html
Market Place
Share 
